tiprankstipranks
Trending News
More News >
ReShape Lifesciences (RSLS)
NASDAQ:RSLS
US Market

ReShape Lifesciences (RSLS) Income Statement

Compare
540 Followers

ReShape Lifesciences Income Statement

Last quarter (Q4 2024), ReShape Lifesciences's total revenue was $1.80M, a decrease of -8.93% from the same quarter last year. In Q4, ReShape Lifesciences's net income was $-1.76M. See ReShape Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 8.01M$ 8.68M$ 11.24M$ 13.60M$ 11.30M
Gross Profit
$ 5.06M$ 5.55M$ 6.80M$ 8.35M$ 6.26M
Operating Expenses
$ 11.72M$ 20.19M$ 33.88M$ 36.10M$ 18.72M
Depreciation and Amortization
$ 0.00$ 154.00K$ 2.15M$ 1.97M$ 1.67M
EBITDA
$ -6.67M$ -14.48M$ -24.93M$ -60.62M$ -18.09M
Operating Income
$ -6.67M$ -14.64M$ -27.08M$ -27.75M$ -12.46M
Other Income/Expenses
$ -423.00K$ 3.30M$ -4.68M$ -12.17M$ -9.35M
Pretax Income
$ -7.09M$ -11.34M$ -46.59M$ -62.04M$ -21.81M
Net Income
$ -7.13M$ -11.39M$ -46.21M$ -61.93M$ -21.63M
Per Share Metrics
Basic EPS
$ -13.83$ -110.88$ -6.32K$ -16.44K$ -48.19K
Diluted EPS
$ -13.83$ -110.88$ -6.32K$ -16.44K$ -48.19K
Weighted Average Shares Outstanding
515.57K 102.70K---
Weighted Average Shares Outstanding (Diluted)
515.57K 102.70K---
Currency in USD

ReShape Lifesciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis